Rezo Therapeutics Launches With $78M in Series A Funding
The firm will initially focus on developing a pipeline of biomarker-guides therapies for solid tumors.
Nucleome Therapeutics Closes £37.5M Series A Financing Round
The British firm will look to expand its atlas of the "dark genome" with 3D mapping to inform drug discovery.
Sophia Genetics Partners With MSK on Clinical Decision Support, Boundless Bio on ecDNA Detection
Sophia will provide Memorial Sloan Kettering with predictive tumor analysis technology and help startup Boundless develop new therapies and MDx methods.
A €4.3 million EU grant is supporting the German firms' work on AI technology to accelerate precision oncology.
Indivumed, CellPhenomics Partner on Cancer Drug Target Research
The two German companies will share tumor data for AI-based in silico target discovery and in vitro validation.
May 27, 2022
May 20, 2022
May 17, 2022
Apr 25, 2022
Jun 24, 2021
Apr 19, 2021